Renal effects of nonselective NSAIDs and coxibs

Matthew R. Weir, MD
Division of Nephrology, University of Maryland School of Medicine, Baltimore

Correspondence: Matthew R. Weir, MD, Professor of Medicine and Director, Division of Nephrology, University of Maryland School of Medicine, 22 South Greene St., Baltimore, MD
21201; e-mail: mweir@medicine.umaryland.edu

The author has indicated that he has received grant or research support from Pharmacia, has been a consultant for Merck and Pharmacia, and is on the speaker’s bureau of Merck.

Matthew R. Weir, MD
Division of Nephrology, University of Maryland School of Medicine, Baltimore

Correspondence: Matthew R. Weir, MD, Professor of Medicine and Director, Division of Nephrology, University of Maryland School of Medicine, 22 South Greene St., Baltimore, MD
21201; e-mail: mweir@medicine.umaryland.edu

The author has indicated that he has received grant or research support from Pharmacia, has been a consultant for Merck and Pharmacia, and is on the speaker’s bureau of Merck.

Matthew R. Weir, MD
Division of Nephrology, University of Maryland School of Medicine, Baltimore

Correspondence: Matthew R. Weir, MD, Professor of Medicine and Director, Division of Nephrology, University of Maryland School of Medicine, 22 South Greene St., Baltimore, MD
21201; e-mail: mweir@medicine.umaryland.edu

The author has indicated that he has received grant or research support from Pharmacia, has been a consultant for Merck and Pharmacia, and is on the speaker’s bureau of Merck.